High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke

Cerebrovascular Diseases

Volumn 22, Issue 5-6, 2006, Pages 368-371

  Ivey, Frederick M ^a,b   Ryan, Alice S ^a,b   Hafer Macko, Charlene E ^a,b   Garrity, Brian M ^a,b   Sorkin, John D ^a,b   Goldberg, Andrew P ^a,b   Macko, Richard F ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Chronically disabled; Post stroke hyperglycemia; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMIPARESIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; STROKE; STROKE PATIENT;

AGED; BLOOD GLUCOSE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33748959373     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094853     Document Type: Article

References (21)

1. Roth EJ: Heart disease in patients with stroke. Part 2. Impact and implications for rehabilitation. Arch Phys Med Rehabil 1994;75:94-101.
2. Sacco RL, Wolf PA., Kannel WB, McNamara PM: Survival and recurrence following stroke. Stroke 1982;13:290-295.
3. Wade DT, Skilbeck CE, Wood VA, Langton HR: Long-term survival after stroke. Age Ageing 1984;13:76-82.
4. Williams GR, Jiang JG, Matchar DB, Samsa GP: Incidence and occurrence of total (first ever and recurrent) stroke. Stroke 1999;30:2523-2528.
5. Antiplatelet Trialists' Collaboration: Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988;296:320-331.
6. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412.
7. Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-240.
8. Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC: Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med 2005;165:227-233.
9. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, McVeety JC, Horwitz RI: Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology 2003;60:1447-1451.
10. Gray CS, Scott JF, French JM, Alberti KG, O'Connell JE: Prevalence and prediction of unrecognized diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 2004;33:71-77.
11. Samanta A, Blandford RL, Burden AC, Castleden CM: Glucose tolerance following strokes in the elderly. Age Ageing 1986;15:111-113.
12. Ryan AS, Dobrovolny CL, Smith GV, Silver KH, Macko RF: Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil 2002;83:1703-1707.
13. DeDeyne PG, Hafer-Macko CE, Ivey FM, Ryan A, Macko RF: Muscle molecular phenotype after stroke is associated with gait deficit severity. Muscle Nerve 2004;30:209-215.
14. Hafer-Macko CE, Yu S, Ryan AS, Ivey FM, Macko RF: Elevated tumor necrosis factor-alpha in skeletal muscle after stroke. Stroke 2005;36:2021-2023.
15. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
16. DECODE Study Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-404.
17. American Diabetes Association: Clinical practice recommendations. Diabetes Care 2005;28(suppl 1):S37-S42.
18. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey. Diabetes Care 1998;21:518-524.
19. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG: Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000;31:2080-2086.
20. Dobrovolny L, Ivey FM, Rogers MA, Sorkin JD, Macko RF: Test-retest reliability of open circuit spirometry treadmill testing in chronic hemiparetic stroke patients. Arch Phys Med Rehabil 2003;84:1308-1312.
21. Perucchini D, Fischer U, Spinas GA, Huch R, Huch A, Lehmann R: Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. BMJ 1999;319:812-815.